The DOI matches its Crossref record; 215 of the 215 references it cites were found in a registry or an index; 13 of the 170 sources its claims cite were checked for support.
The technological landscape and applications of single-cell multi-omics
Open accessAbstract
Single-cell multi-omics technologies and methods characterize cell states and activities by simultaneously integrating various single-modality omics methods that profile the transcriptome, genome, epigenome, epitranscriptome, proteome, metabolome and other (emerging) omics. Collectively, these methods are revolutionizing molecular cell biology research. In this comprehensive Review, we discuss established multi-omics technologies as well as cutting-edge and state-of-the-art methods in the field. We discuss how multi-omics technologies have been adapted and improved over the past decade using a framework characterized by optimization of throughput and resolution, modality integration, uniqueness and accuracy, and we also discuss multi-omics limitations. We highlight the impact that single-cell multi-omics technologies have had in cell lineage tracing, tissue-specific and cell-specific atlas production, tumour immunology and cancer genetics, and in mapping of cellular spatial information in fundamental and translational research. Finally, we discuss bioinformatics tools that have been developed to link different omics modalities and elucidate functionality through the use of better mathematical modelling and computational methods. Single-cell multi-omics methods are essential for characterizing cell states and types. The past decade has ushered in improvements in spatial resolution and computational data integration and in new omics modalities. Consequently, single-cell multi-omics have advanced fundamental and translational research, including, for example, in production of cell atlases and in tumour immunology therapeutics.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This comprehensive Review surveys single-cell multi-omics technologies, their decade of development, spatial extensions, applications, and computational integration tools. It argues these methods are transforming cell lineage tracing, atlas production, tumour immunology/cancer genetics, and spatial mapping, while highlighting benchmarking, cost, coverage, and throughput limitations.
Key findings
- The review organizes multi-omics around transcriptome-anchored pairings with genome, epigenome, proteome, and emerging modalities; Table 1 lists methods from 2014 to 2023, including spatial resolutions from 100 μm (spatial transcriptomics) to 2 μm (HDST) and DBiT-seq at 10–50 μm.
- Throughput has increased markedly: SPLiT-seq uniquely labelled over 100,000 nuclei in one experiment; Paired-seq processed 1 million nuclei; Perturb-seq analysed 200,000 cells; Sci-CAR-seq profiled over 11,200 nuclei; SNARE-seq co-profiled over 10,000 mRNA transcripts with chromatin accessibility; TEA-seq measured thousands of single cells.
- Applications include lineage tracing, cell atlases, tumour immunology and cancer genetics: TCGA characterizes over 20,000 primary cancer and matched normal samples from 33 cancer types; HCA launched in 2017; CXCL13+CD8+ T cells correlated with favourable ICB response; RUNX1 was identified as a potential oncogene in mixed-phenotype acute leukaemia; CAR T ALL analysis implicated TH2 pathways and related genes in 5-year remission.
- Computational integration is classified as matched versus unmatched; examples include Seurat v3 and LIGER, GLUE for triple-omics integration, Seurat v4 weighted nearest-neighbour analysis, DeepMAPS, SCENIC+, FigR, MIRA, CellOracle, and MultiVelo.
Methods
- Design: comprehensive Review, not primary experimental research; synthesizes established and cutting-edge single-cell multi-omics technologies and bioinformatics tools.
- Data or sample: no primary experimental sample; based on published literature and three summary tables — Table 1 (single-cell and spatial omics methods by date), Table 2 (multi-omics contributions to cell atlases), and Table 3 (computational methods).
- Main analysis: narrative synthesis organized by modality integration (genome–transcriptome, transcriptome–epigenome, transcriptome–proteome, other modalities), spatial multi-omics, research and clinical applications, and computational integration.
Limitations
- Stated in the paper: benchmarking emerging computational tools is crucial; matched or same-experiment datasets and gold-standard datasets are difficult to obtain; high sequencing costs and limited coverage of single cells; long-read technologies face low sequencing accuracy and difficulty obtaining intact DNA and full-length RNA from clinical samples; most spatial technologies are low throughput and have relatively small capture areas, limiting 3D tissue profiling; pseudotime methods are not always accurate in reconstructing complex developmental trajectories.
- Evident from the text: as a review, it presents no new experimental data or meta-analysis, and its coverage is selective rather than systematic — the authors state they “only highlight atlases encompassing multi-omics datasets” and that described technologies are “just some of the many examples.”
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
108 Not checked yet · 27 Own interpretation · 11 No basis given · 4 Partly supported · 3 Supported · 1 Supported so far · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Overcoming these shortcomings, we reported the first amplification and sequencing of a whole genome and whole transcriptome from a single cell using a microfluidics-facilitated technology in 2014, which captured single cells using microvalve-based control channels, selectively lysed and separated cytoplasmic and nuclear contents, and then performed on-chip amplification, thereby enabling multiple”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
What the sources say
- Partly supportedcites [20] Han, L. et al. Co-detection and sequencing of genes and transcripts from the same single cells facilitated by a microfluidics platform. Sci. Rep. 4, 6485 (2014). sourceExperimental — accuracy not yet measured
The Abstract describes a microfluidic platform that separates and amplifies genomic DNA and mRNA from the same single cell, and says it could enable multiple genomic measurements. It also says sequencing was limited to a panel of genes and transcripts using off-chip PCR and Sanger sequencing; it does not report sequencing the whole genome and whole transcriptome. (LLM, conf=0.90)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Subsequently, DNA methylation co-profiling technologies were developed for tri-omics analysis: single-cell triple omics sequencing (scTrio-seq) combined profiling of genome, methylome and transcriptome in 25 single cancer cells by applying scRRBS and whole-genome sequencing33;”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Partly supportedcites [33] Hou, Y. et al. Single-cell triple omics sequencing reveals genetic, epigenetic, and transcriptomic heterogeneity in hepatocellular carcinomas. Cell Res. 26, 304–319 (2016). sourceExperimental — accuracy not yet measured
The Introduction and Results (page numbers not provided) say scTrio-seq analyzed 25 HCC cancer cells and obtained genomic CNV, methylome, and transcriptome information using scRRBS data. The CNV deduction Results section says whole-genome DNA amplification could not be performed alongside bisulfite conversion in a single cell; CNVs were instead inferred from RRBS data. Thus, the claim's whole-genome sequencing component is not supported. (LLM, conf=0.90)
plainn = 25- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“For example, in 2016, the proximity ligation assay for RNA (PLAYR) was developed to simultaneously quantify more than 40 targeted mRNAs and proteins from 10,000 single cells in several cell types67.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and proteome
What the sources say
- Partly supportedcites [67] Frei, A. P. et al. Highly multiplexed simultaneous detection of RNAs and proteins in single cells. Nat. Methods 13, 269–275 (2016). sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says PLAYR enables simultaneous quantitative measurement of more than 40 proteins and RNAs, and the Results describe its use with multiple cell types. The Discussion reports hundreds to thousands of intact cells measured per second, but our copy does not substantiate the specific figure of 10,000 single cells. (LLM, conf=0.85)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Furthermore, this study led to the discovery of key factors in the gene–metabolite interaction network, metabolites, cell cycle genes and genes of the p53 signalling pathway, which may have important roles in disease mechanisms.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tumour immunology and cancer genetics
What the sources say
- Supportedcites [159] Hoang, L. T. et al. Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer. Mol. Oncol. 13, 2406–2421 (2019). source
The Discussion identifies key metabolites in the gene–metabolite interaction network as potentially important in disease mechanisms. It also identifies cell-cycle checkpoint and p53-signalling genes, particularly in LUSC tumours. (LLM, conf=0.94)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“These include SCENIC+176, functional inference of gene regulation (FigR)177, and probabilistic multimodal models for integrated regulatory analysis (MIRA)178, which model joint variation across paired transcriptomic and scATAC-seq measurements to link enhancers to genes and to identify transcription factors that drive cellular decisions.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Supportedcites [176] Gonzalez-Blas, C. SCENIC+: single-cell multiomic inference of enhancers and gene regulatory networks. Preprint at bioRxiv https://doi.org/10.1101/2022.08.19.504505 (2022). source
The SCENIC+ workflow (p. 16) combines chromatin accessibility and gene expression to predict enhancer-driven regulatory networks. The methods (p. 19) say it accepts single-cell multiome data or paired scRNA-seq and scATAC-seq from matching populations; the opening passage (p. 1) says it links enhancers to target genes, predicts cell-state-specific transcription factors, and studies regulation along differentiation trajectories. This verdict concerns SCENIC+ only, not the separately cited FigR and MIRA methods. (LLM, conf=0.91)
- Supportedcites [177] Kartha, V. Functional inference of gene regulation using single-cell multi-omics. Cell Genom. 2, 100166 (2022). source
The Abstract identifies FigR as a framework that pairs scATAC-seq and scRNA-seq cells, connects distal regulatory elements to genes, and identifies candidate transcription-factor regulators. The Discussion says FigR uses variation in chromatin accessibility and RNA expression across single cells to infer regulatory relationships spanning cell states. Citation 177 identifies FigR specifically; this verdict does not assess the other two methods in the citing sentence. (LLM, conf=0.91)
- Supportedcites [178] Lynch, A. MIRA: joint regulatory modeling of multimodal expression and chromatin accessibility in single cells. Nat. Methods 19, 1097–1108 (2021). source
The Results section describes MIRA’s joint modeling of single-cell expression and chromatin accessibility and its gene-level analysis of how surrounding regulatory elements influence expression. It also says MIRA predicts key regulators, while the Discussion says it identifies regulators driving fate decisions at trajectory branch points. The citation to this paper is attached to MIRA, not to SCENIC+ or FigR. (LLM, conf=0.92)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“Several scRNA-seq methods developed in the recent decade have become essential for capturing intercellular variation and its impact on cell functions at the population scale15–19.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
What the sources say
- Not checked yetcites [15] Hashimshony, T., Wagner, F., Sher, N. & Yanai, I. CEL-seq: single-cell RNA-seq by multiplexed linear amplification. Cell Rep. 2, 666–673 (2012). source
- Not checked yetcites [16] Islam, S. et al. Highly multiplexed and strand-specific single-cell RNA 5′ end sequencing. Nat. Protoc. 7, 813–828 (2012). source
- Not checked yetcites [17] Jaitin, D. A. et al. Massively parallel single-cell RNA-seq for marker-free decomposition of tissues into cell types. Science 343, 776–779 (2014). source
- Not checked yetcites [18] Ramskold, D. et al. Full-length mRNA-seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 30, 777–782 (2012). source
- Not checked yetcites [19] Sasagawa, Y. et al. Quartz-Seq: a highly reproducible and sensitive single-cell RNA sequencing method, reveals non-genetic gene-expression heterogeneity. Genome Biol. 14, R31 (2013). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Methodological and technological advances now allow the simultaneous profiling of genome, epigenome, transcriptome, proteome and other (emerging) omics modalities in an effort to better understand biological mechanisms and genotype-to-phenotype relationships.”
§ The technological landscape and applications of single-cell multi-omics > Introduction
What the sources say
- Not checked yetcites [1] Lee, J., Hyeon, D. Y. & Hwang, D. Single-cell multiomics: technologies and data analysis methods. Exp. Mol. Med. 52, 1428–1442 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Over the past decade, single-cell multi-omics technologies have been developed to directly characterize the phenotypes that are usually inferred only from single-omics methods.”
§ The technological landscape and applications of single-cell multi-omics > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Parallel profiling of the genome and transcriptome of the same single cell can reflect the transcriptional state of the genome.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Single-cell epigenome analysis in tandem with transcriptomics allows the direct elucidation of DNA epigenetic features such as DNA methylation, DNA accessibility and histone modifications in relation to the transcriptome they produce.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 57
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The field has rapidly developed ever since and is divided into two major categories: microfluidics droplet-based transcriptomics7–10 and microwell plate-based11–13 transcriptomics (Box 1).”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
What the sources say
- Not checked yetcites [7] Gierahn, T. M. et al. Seq-Well: portable, low-cost RNA sequencing of single cells at high throughput. Nat. Methods 14, 395–398 (2017). source
- Supportedcites [8] Klein, A. M. et al. Droplet barcoding for single-cell transcriptomics applied to embryonic stem cells. Cell 161, 1187–1201 (2015). source
The citation is attached to the droplet-based transcriptomics category, not the microwell plate-based category. The Introduction and Results (page numbers not provided) identify this paper's inDrop method as droplet-microfluidic RNA sequencing of single cells. (LLM, conf=0.93)
- Supportedcites [9] Macosko, E. Z. et al. Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell 161, 1202–1214 (2015). source
The citation is attached to the droplet-based transcriptomics category, not specifically to the claim that the field has exactly two categories. The Introduction and Results identify Drop-Seq as a single-cell transcriptomics method that uses a microfluidic device to encapsulate cells in droplets. (LLM, conf=0.93)
- Supportedcites [10] Zheng, G. X. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017). source
This source is cited in the group attached to “microfluidics droplet-based transcriptomics,” not the separate group attached to plate-based methods. The Results section (“Droplet-based platform enables barcoding of cells”) describes its scRNA-seq platform as using an 8-channel microfluidic chip to generate droplets, so it is an example of the cited category. (LLM, conf=0.93)
- Supportedcites [11] Hagemann-Jensen, M. et al. Single-cell RNA counting at allele and isoform resolution using Smart-seq3. Nat. Biotechnol. 38, 708–714 (2020). source
The citation is attached to the microwell plate-based category, and this paper describes Smart-seq3 as a plate-based single-cell transcriptomics method. The Discussion says its implementation uses 384-well plates, and the Supplementary Methods describe distributing individual cells into 96- or 384-well plates. This supports the citation as an example of that category, rather than as evidence for the field-wide two-category division. (LLM, conf=0.90)
- Not checked yetcites [12] Natarajan, K. N. Single-cell tagged reverse transcription (STRT-seq). Methods Mol. Biol. 1979, 133–153 (2019). source
- Not checked yetcites [13] Picelli, S. et al. Full-length RNA-seq from single cells using Smart-seq2. Nat. Protoc. 9, 171–181 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Every source the paper cites for this claim was checked and supports it.
In the paper
“scNOMe-seq characterizes nucleosome positioning, chromatin accessibility and DNA methylation by uniquely recovering reads regardless of signal and allelic drop-outs, thereby distinguishing them from reads of inaccessible chromatin35.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Supportedcites [35] Pott, S. Simultaneous measurement of chromatin accessibility, DNA methylation, and nucleosome phasing in single cells. eLife https://doi.org/10.7554/eLife.23203 (2017). source
The Discussion states that scNOMe-seq measures chromatin accessibility and endogenous DNA methylation, and that it was used to estimate nucleosome phasing distances. It also says reads are recovered independently of the accessibility signal, allowing allelic drop-out to be distinguished from closed or inaccessible chromatin. The paper describes nucleosome phasing rather than direct measurement of every nucleosome position. (LLM, conf=0.91)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This method has been modified further by other groups to profile histone modifications at the single-cell level: methods such as scCUT&Tag48 and scCUT&Tag2for149 use tagmentation directed by antibodies to profile active and silenced regulatory elements genome-wide by targeting domains bound by, respectively, RNA polymerase II and Polycomb repressive complexes.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Partly supportedcites [48] Bartosovic, M., Kabbe, M. & Castelo-Branco, G. Single-cell CUT&Tag profiles histone modifications and transcription factors in complex tissues. Nat. Biotechnol. 39, 825–835 (2021). sourceExperimental — accuracy not yet measured
The Results (‘CUT&Tag profiling of single cells’; page unavailable) confirm that scCUT&Tag uses antibody-directed tagmentation, and the paper profiles histone marks associated with active and repressive genomic regions. But the Online Methods (‘Antibodies’; page unavailable) list histone marks, Rad21 and Olig2—not RNA polymerase II. This source also does not describe scCUT&Tag2for1, which has a separate citation in the citing sentence. (LLM, conf=0.88)
- Not checked yetcites [49] Janssens, D. H. et al. CUT&Tag2for1: a modified method for simultaneous profiling of the accessible and silenced regulome in single cells. Genome Biol. 23, 81 (2022). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The most mature of the single-cell omics methods, single-cell transcriptomics, is often paired with other omics to study the connection between gene expression and phenotypic heterogeneity in an unbiased manner (Fig. 2).”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Continuous advancements in multiplexing, throughput, resolution and accuracy in single-cell multi-omics technologies have aided the comprehensive delineation of the genetic landscape of a cell and revolutionized our capacity to identify cellular heterogeneities and relationships (Table 1).”
§ The technological landscape and applications of single-cell multi-omics > Introduction
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“By using laser capture microdissection (LCM), robotic micromanipulation, fluorescence-activated cell sorting or microfluidic platforms1, single cells can be isolated into individual compartments where they undergo barcoding of multiple types of molecules, thereby enabling genome-scale characterization of cell-type-specific genomic information at an unprecedented resolution.”
§ The technological landscape and applications of single-cell multi-omics > Introduction
What the sources say
- Not checked yetcites [1] Lee, J., Hyeon, D. Y. & Hwang, D. Single-cell multiomics: technologies and data analysis methods. Exp. Mol. Med. 52, 1428–1442 (2020). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In 2009, the first single-cell genome-wide mRNA sequencing (scRNA-seq) method was reported6, thanks in part to the emergence of next-generation sequencing (NGS).”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
What the sources say
- Not checked yetcites [6] Tang, F. et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods 6, 377–382 (2009). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Single-cell sequencing was designated ‘Method of the Year’ in 2013 owing to its availability, versatility and robustness14.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
What the sources say
- Not checked yetcites [14] No Authors Listed. Method of the year 2013. Nat. Methods 11, 1 (2014). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“The broad implementation of these technologies has been transformative in enabling applications such as tracing cell lineages3, producing cell-type atlases of various organs4 and dissecting mechanisms in disease settings such as tumour immunology and cancer genetics5.”
§ The technological landscape and applications of single-cell multi-omics > Introduction
What the sources say
- Not checked yetcites [3] Wagner, D. E. & Klein, A. M. Lineage tracing meets single-cell omics: opportunities and challenges. Nat. Rev. Genet. 21, 410–427 (2020). source
- Not checked yetcites [4] Elmentaite, R., Domínguez Conde, C., Yang, L. & Teichmann, S. A. Single-cell atlases: shared and tissue-specific cell types across human organs. Nat. Rev. Genet. 23, 395–410 (2022). source
- Not checked yetcites [5] Yofe, I., Dahan, R. & Amit, I. Single-cell genomic approaches for developing the next generation of immunotherapies. Nat. Med. 26, 171–177 (2020). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“As single-cell technologies have continually advanced, emerging methods capable of spatially mapping gene expression within the tissue drove the conception of ‘spatial multi-omics’.”
§ The technological landscape and applications of single-cell multi-omics > Introduction
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These technologies have generated a huge amount of data that enable the discovery of mechanisms of gene regulation, protein expression dynamics, epigenetic variation and cell perturbation models, which have revolutionized how we understand cell heterogeneity in health and disease (Fig. 1).”
§ The technological landscape and applications of single-cell multi-omics > Introduction
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“On its own, scRNA-seq is unable to provide coverage of key mutations and does not provide genome–transcriptome correlations in cells that ultimately lead to the discovery of novel gene-expression programmes in disease.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Single-cell DNA methylation profiling methods with single-base resolution can be categorized according to two core technologies: reduced-range bisulfite sequencing (RRBS) and whole-genome bisulfite sequencing (WGBS), both using bisulfite conversion followed by NGS.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“DNA methylation at CpG islands generally regulates gene expression25.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [25] Moore, D. DNA methylation and its basic function. Neuropsychopharmacology 38, 23–38 (2013). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The primary differences between the two categories are coverage and cost: WGBS has higher coverage of CpG islands in the genome whereas RRBS is less expensive.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Droplet-based methods can analyse single cells at a much higher throughput (thousands of cells profiled at once) by utilizing microfluidic devices, but only from the 5′ or 3′ end of the transcript, thereby omitting the detection of allele-specific expression and other isoforms.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Plate-based methods can generate full-length transcripts that carry ample information to allow detection of genes that are not highly expressed and other rare transcripts.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Chromatin accessibility is integral to detecting genomic activity as it reveals enhancer activity, transcription factor binding sites and other DNA regulatory elements.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Adding to the comprehensive tri-omics methods and WGBS technologies is single-cell nucleosome occupancy mapping, which is demonstrated in scNMT-seq29 and scNOMeRe-seq36 and by which DNA methylation, chromatin accessibility and transcripts from the same DNA molecule can be profiled.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [29] Clark, S. J. et al. scNMT-seq enables joint profiling of chromatin accessibility DNA methylation and transcription in single cells. Nat. Commun. 9, 781 (2018). source
- Not checked yetcites [36] Wang, Y. et al. Single-cell multiomics sequencing reveals the functional regulatory landscape of early embryos. Nat. Commun. 12, 1247 (2021). source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“These methods require both high quantity and high quality of cells.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Both methods are similar in that DNA and RNA must be physically separated, which may result in loss of genetic material and sensitivity or in amplification bias, which limits the ability to confidently detect small pathogenic alterations.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The next year, genome and transcriptome sequencing (G&T-seq)21 and gDNA–mRNA sequencing (DR-seq)22 were reported.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
What the sources say
- Not checked yetcites [21] Macaulay, I. C. et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat. Methods 12, 519–522 (2015). source
- Not checked yetcites [22] Dey, S. S., Kester, L., Spanjaard, B., Bienko, M. & van Oudenaarden, A. Integrated genome and transcriptome sequencing of the same cell. Nat. Biotechnol. 33, 285–289 (2015). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In 2019, TARGET-seq, a plate-based method, demonstrated increased throughput of ~5,000 single cells profiled per run through the use of barcoding and pooling of libraries in reduced reaction volumes and was set apart from previously mentioned methods by improving mutation coverage using protein digestion, which improves the release of DNA and RNA during cell lysis23.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating genome and transcriptome
What the sources say
- Not checked yetcites [23] Rodriguez-Meira, A. et al. Unravelling intratumoral heterogeneity through high-sensitivity single-cell mutational analysis and parallel RNA sequencing. Mol. Cell 73, 1292 (2019). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Building on scRNA-seq, multi-omics technologies preserve the progress made in characterizing transcriptomic information while simultaneously capturing other modalities and increasing throughput through cell multiplexing, cell tagging, cell hashing and other methods (Fig. 3).”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, these methods are limited by plate size and the quantity of cells available for analysis.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The first method of WGBS multi-omics, single-cell genome-wide methylome and transcriptome sequencing (scM&T-seq)28, borrowed already-established single-omics techniques from G&T-seq21 and scBS-seq26 to measure DNA methylation heterogeneity in single cells, combined with Smart-seq2 to generate transcriptional data concurrently with genome-wide methylation data.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [28] Angermueller, C. et al. Parallel single-cell sequencing links transcriptional and epigenetic heterogeneity. Nat. Methods 13, 229–232 (2016). source
- Not checked yetcites [21] Macaulay, I. C. et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat. Methods 12, 519–522 (2015). source
- Not checked yetcites [26] Smallwood, S. A. et al. Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat. Methods 11, 817–820 (2014). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Histone modifications at single-cell resolution are informative in understanding epigenetic programmes and differentiation trajectories of cells, thereby aiding in cell-state prediction.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition to the well-established chromatin immunoprecipitation followed by sequencing (ChIP–seq)45 and CUT&RUN46 methods, cleavage under targets and tagmentation (CUT&Tag), which was developed in 2019, uses Tn5 transposase to directly tagment the antibody binding site47.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [47] Kaya-Okur, H. S. et al. CUT&Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 10, 1930 (2019). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“ATAC-seq allows the identification of regions within the genome that have open chromatin states associated with transcription in low numbers of cells and is an easy and time-friendly method as it does not include extraction or enzymatic-digestion steps.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [37] Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Medium-throughput methods involving manipulation of intact cells rather than nuclei and profiling both epigenome and transcriptome such as scCAT-seq53 and assay for single-cell transcriptome and accessibility regions (ASTAR-seq)54 have been developed.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [53] Liu, L. et al. Deconvolution of single-cell multi-omics layers reveals regulatory heterogeneity. Nat. Commun. 10, 470 (2019). source
- Not checked yetcites [54] Xing, Q. R. et al. Parallel bimodal single-cell sequencing of transcriptome and chromatin accessibility. Genome Res. 30, 1027–1039 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Increasing throughput, SHARE-seq was built based on SPLiT-seq and Paired-seq and uses several rounds of hybridization blocking to label mRNA and chromatin fragments in single cells60.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [60] Ma, S. et al. Chromatin potential identified by shared single-cell profiling of RNA and chromatin. Cell 183, 1103 (2020). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This strategy was implemented shortly after by Paired-seq, which used three rounds of ligation-based combinatorial indexing to process 1 million nuclei in a single experiment for parallel transcriptome and chromatin accessibility analyses59.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [59] Zhu, C. et al. An ultra high-throughput method for single-cell joint analysis of open chromatin and transcriptome. Nat. Struct. Mol. Biol. 26, 1063–1070 (2019). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Another recent high-throughput method, ISSAAC-seq (in situ sequencing hetero RNA–DNA-hybrid after assay for transposase-accessible chromatin sequencing), used a two-tagmentation strategy: an initial tagmentation reaction on accessible chromatin followed by reverse transcription and another tagmentation reaction on cDNA–RNA hybrids62.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
What the sources say
- Not checked yetcites [62] Xu, W. et al. ISSAAC-seq enables sensitive and flexible multimodal profiling of chromatin accessibility and gene expression in single cells. Nat. Methods 19, 1243–1249 (2022). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Another method, Mosaic-seq, was developed to systematically perturb enhancers and measure their endogenous activities while jointly measuring the transcriptome at single-cell resolution86.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Other multi-omics modalities
What the sources say
- Not checked yetcites [86] Xie, S., Duan, J., Li, B., Zhou, P. & Hon, G. C. Multiplexed engineering and analysis of combinatorial enhancer activity in single cells. Mol. Cell 66, 285–299.e5 (2017). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In 2016, CRISP-seq, a method to capture mRNA and genomic perturbations from CRISPR-pooled screens emerged, elucidating the function of multiple regulatory factors in a single experiment85.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Other multi-omics modalities
What the sources say
- Not checked yetcites [85] Jaitin, D. A. et al. Dissecting immune circuits by linking CRISPR-pooled screens with single-cell RNA-seq. Cell 167, 1883–1896.e15 (2016). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“CRISPR screens have been coupled with other methods such as scATAC-seq — for example, in developing Spear-ATAC-seq, which characterized over 100,000 single-cell epigenetic states and over 400 CRISPR perturbations87.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Other multi-omics modalities
What the sources say
- Not checked yetcites [87] Pierce, S. E., Granja, J. M. & Greenleaf, W. J. High-throughput single-cell chromatin accessibility CRISPR screens enable unbiased identification of regulatory networks in cancer. Nat. Commun. 12, 2969 (2021). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“These data can provide an in-depth understanding of immunity spectra in individuals and suggest how various receptor configurations contribute to adaptive immunity responses, autoimmunity and tumour growth88.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Other multi-omics modalities
What the sources say
- Not checked yetcites [88] Pai, J. A. & Satpathy, A. T. High-throughput and single-cell T cell receptor sequencing technologies. Nat. Methods 18, 881–892 (2021). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: TCRs and BCRs are crucial components of adaptive immunity.
In the paper
“Finally, expanded CRISPR-compatible CITE-seq (ECCITE-seq) expanded the protein multi-omics field to incorporate CRISPR-compatible transcriptome, immunity repertoire and proteome indexing, including both clonotype profiling and CRISPR-directed perturbations at high sensitivity and single-cell resolution81.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and proteome
What the sources say
- Not checked yetcites [81] Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409–412 (2019). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Other single-cell proteomics methods that do not rely on antibodies produce a more comprehensive characterization of the cellular proteome, as they are not limited by antigen-specific reagents and can profile thousands of proteins in single cells.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and proteome
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SCoPE-MS and SCoPE2 are such methods using mass spectrometry, but they have no available integration method with other omics, leaving room for future development72,73.”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and proteome
What the sources say
- Not checked yetcites [72] Budnik, B., Levy, E., Harmange, G. & Slavov, N. SCoPE-MS: mass spectrometry of single mammalian cells quantifies proteome heterogeneity during cell differentiation. Genome Biol. 19, 161 (2018). source
- Not checked yetcites [73] Specht, H. et al. Single-cell proteomic and transcriptomic analysis of macrophage heterogeneity using SCoPE2. Genome Biol. 22, 50 (2021). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“To assess both RNA and proteins, RNAscope, commercialized in 2011 by Advanced Cell Diagnostics103, hybridizes DNA with probes tagged with metal instead of fluorophores, followed by the addition to the tissue section of metal-conjugated antibodies and mass-cytometry measurements of metal abundance104,105.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Imaging-based technologies
What the sources say
- Not checked yetcites [103] Bio-Techne. Bio-Techne announces commercial release of RNAscope® HiPlex Assay: a multiplex in situ hybridization assay for tissues, https://investors.bio-techne.com/press-releases/detail/148/bio-techne-announces-commercial-release-of-rnascope (2016).
- Not checked yetcites [104] Schulz, D. et al. Simultaneous multiplexed imaging of mRNA and proteins with subcellular resolution in breast cancer tissue samples by mass cytometry. Cell Syst. 6, 531 (2018). source
- Not checked yetcites [105] Wang, F. et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 14, 22–29 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The aforementioned single-cell multi-omics methods require dissociation of cells from their tissue and thus lose information about physical interactions within and between cells, despite several computational efforts made to infer cell–cell interactions96,97.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial
What the sources say
- Not checked yetcites [96] Efremova, M., Vento-Tormo, M., Teichmann, S. A. & Vento-Tormo, R. CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes. Nat. Protoc. 15, 1484–1506 (2020). source
- Not checked yetcites [97] Browaeys, R., Saelens, W. & Saeys, Y. NicheNet: modeling intercellular communication by linking ligands to target genes. Nat. Methods 17, 159–162 (2020). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Organization of cellular compartments and intercellular interactions is fundamental to the function of multicellular organisms.
In the paper
“The spatial proteomics field has also expanded with the development of technologies such as co-detection by indexing (CODEX), which uses a multiplexed cytometric imaging approach to quantitatively characterize protein expression and define tissue architecture112.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Imaging-based technologies
What the sources say
- Not checked yetcites [112] Goltsev, Y. et al. Deep profiling of mouse splenic architecture with CODEX multiplexed imaging. Cell 174, 968–981.e15 (2018). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“LCM-based methods allow full gene or protein profiling at a single-cell level including positional information, but they can assay only a small number of cells.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Laser capture microdissection-based technologies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Expanding to spatial mapping of T-cell clonotype repertoires, Slide-TCR-seq was recently reported to sequence whole transcriptomes and TCRs by integrating Slide-seqV2 with rhTCR-seq131 (a method used to amplify TCR transcripts), revealing the interaction between clonality, neighbouring cell types and gene expression in tissues at single-cell resolution132.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Sequencing-based technologies
What the sources say
- Not checked yetcites [131] Li, S. et al. RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis. Nat. Protoc. 14, 2571–2594 (2019). source
- Not checked yetcites [132] Liu, S. et al. Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response. Immunity 55, 1940–1952.e5 (2022). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Combined spatial transcriptomics or the Visium platform with CITE-seq chemistry, SM-Omics129 and SPOTS130 also achieved co-analysis of transcriptome and a panel of proteins in tissue sections, although not at single-cell resolution.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Sequencing-based technologies
What the sources say
- Not checked yetcites [129] Vickovic, S. et al. SM-Omics is an automated platform for high-throughput spatial multi-omics. Nat. Commun. 13, 795 (2022). source
- Not checked yetcites [130] Ben-Chetrit, N. et al. Integration of whole transcriptome spatial profiling with protein markers. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01536-3 (2023). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“GeoMx (from Nanostring) uses a targeted FISH detection method rather than direct sequencing of transcripts, allowing the detection of up to 10,000 genes in a select microscopic region of tissue through photocleaving and sequencing the DNA probes, which are hybridized to target genes, and the probe panel is now approaching a whole-transcriptome level of coverage121.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Sequencing-based technologies
What the sources say
- Not checked yetcites [121] Merritt, C. R. et al. Multiplex digital spatial profiling of proteins and RNA in fixed tissue. Nat. Biotechnol. 38, 586–599 (2020). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In 2016, spatial transcriptomics was introduced116, demonstrating a 100-μm spot size on a microarray slide with arrayed oligonucleotides to capture spatial gene expression information.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Sequencing-based technologies
What the sources say
- Not checked yetcites [116] Ståhl, P. L. et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science 353, 78–82 (2016). source
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recently, DBiT-seq has further demonstrated its versatility by spatial co-profiling of mRNA transcriptome and hundreds of cellular proteins as part of spatial CITE-seq126 and of transcriptome and epigenome as part of spatial ATAC–RNA-seq127, spatial CUT&Tag–RNA-seq127 and (reported in a preprint) SPARC-seq128.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Sequencing-based technologies
What the sources say
- Not checked yetcites [126] Liu, Y. et al. High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq. Nat. Biotechnol. https://doi.org/10.1038/s41587-023-01676-0 (2023). source
- Not checked yetcites [127] Zhang, D. et al. Spatial epigenome–transcriptome co-profiling of mammalian tissues. Nature 616, 113–122 (2023). source
- Not checked yetcites [128] Jiang, F. et al. Simultaneously spatiotemporal gene expression and chromatin accessibility for mouse brain development. Preprint at bioRxiv, https://doi.org/10.1101/2022.03.22.485333 (2022). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Multiple modalities can be characterized simultaneously based on LCM, as demonstrated in a work that constructed dynamic regulatory networks by co-profiling of mRNAs, microRNAs, DNA methylation and protein expression133.”
§ The technological landscape and applications of single-cell multi-omics > Multi-omics goes spatial > Laser capture microdissection-based technologies
What the sources say
- Not checked yetcites [133] Ding, J. et al. Integrating multiomics longitudinal data to reconstruct networks underlying lung development. Am. J. Physiol. Lung Cell Mol. Physiol. 317, L556–L568 (2019). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The Encyclopedia of DNA Elements (ENCODE) project consortium was piloted in 2003 and has since scaled up to define and annotate functional elements in both human and mouse genomes using multi-omics sequencing148.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Production of cell-type atlases of various organs
What the sources say
- Not checked yetcites [148] Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The recently developed iTracer combines reporter barcodes with inducible CRISPR–Cas9 in induced pluripotent stem cell-derived organoids, and is compatible with single-cell and spatial transcriptomics140.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tracing cell lineages
What the sources say
- Not checked yetcites [140] He, Z. Lineage recording in human cerebral organoids. Nat. Methods 19, 90–99 (2022). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Finally, combining genome, transcriptome and lineage reporter methods enables lineage tracing in diseases such as cancer, in which elucidating the persistence of epigenetic states together with genetic mutations can lay a foundation for rational design of therapeutics, as shown by a study elucidating the relevance of single-cell lineages in glioblastoma drug resistance142.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tracing cell lineages
What the sources say
- Not checked yetcites [142] Eyler, C. E. et al. Single-cell lineage analysis reveals genetic and epigenetic interplay in glioblastoma drug resistance. Genome Biol. 21, 174 (2020). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: Clonal information can be encoded by DNA oligonucleotide barcodes to record all cell division events within an organism.
In the paper
“The Cancer Genome Atlas (TCGA) is a cancer-specific multi-omics data resource characterizing over 20,000 primary cancer and corresponding normal samples from 33 cancer types, representing data from genomic, epigenomic, transcriptomic and proteomic modalities.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Production of cell-type atlases of various organs
What the sources say
- Not checked yetcites [147] Cancer Genome Atlas Research Network et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113–1120 (2013). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Altogether, single-cell multi-omics has had a large impact on cell lineage classification for disease, tumour classification and our understanding of evolution of cell states and types.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tracing cell lineages
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
In the paper
“Another group performed integrative analysis of metabolomics, transcriptomics and genetic data to confirm metabolic pathways in non-small-cell lung cancer and elucidate metabolites and genes contributing to platelet activation, haemostasis, angiogenesis and cell proliferation159.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tumour immunology and cancer genetics
What the sources say
- Not checked yetcites [159] Hoang, L. T. et al. Metabolomic, transcriptomic and genetic integrative analysis reveals important roles of adenosine diphosphate in haemostasis and platelet activation in non-small-cell lung cancer. Mol. Oncol. 13, 2406–2421 (2019). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Integrated analysis of transcriptomics and metabolomics revealed that CPT1A overexpression is detrimental to individuals with prostate cancer and may support disease progression.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tumour immunology and cancer genetics
What the sources say
- Not checked yetcites [158] Joshi, M. CPT1A over-expression increases reactive oxygen species in the mitochondria and promotes antioxidant defenses in prostate cancer. Cancers 12, 3431 (2020). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The method was applied to a mouse metastasis model and to primary human cancer, revealing spatially distinct clonal populations and uncovering genes associated with clonal variation and the local tumour microenvironment.”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tumour immunology and cancer genetics
What the sources say
- Not checked yetcites [157] Zhao, T. et al. Spatial genomics enables multi-modal study of clonal heterogeneity in tissues. Nature 601, 85–91 (2022). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, more comprehensive and transformative insights were generated in immuno-oncology research, including but not limited to defining tumour and immune cell states and revealing the interplay between them in specific disease contexts, inferring the complex nature of antigen–immune receptor dynamics, identifying predictive biomarkers of treatment response and providing directions for the”
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tumour immunology and cancer genetics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Different omics layers contain distinct feature spaces that can reveal the underlying mechanisms of the regulation and functionality of diverse cell types, thereby providing a comprehensive understanding of cellular processes (Fig. 4c).”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“A general solution to this obstacle is to project cells into a co-embedded space or nonlinear manifold to find a commonality between all cells.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
None of the sources cited for this claim have been checked yet.
In the paper
“By contrast, paired experimental methods (10x Multiome, SHARE-seq60, DBiT-seq123, SNARE-seq57, CITE-seq68 and others) are easier to work with computationally as different modalities can be tethered to a single cell or a single spot; however, the sequencing capacity of each modality causes the overall sample size to decrease.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [60] Ma, S. et al. Chromatin potential identified by shared single-cell profiling of RNA and chromatin. Cell 183, 1103 (2020). source
- Not checked yetcites [123] Liu, Y. et al. High-spatial-resolution multi-omics sequencing via deterministic barcoding in tissue. Cell 183, 1665–1681.e18 (2020). source
- Not checked yetcites [57] Chen, S., Lake, B. B. & Zhang, K. High-throughput sequencing of the transcriptome and chromatin accessibility in the same cell. Nat. Biotechnol. 37, 1452–1457 (2019). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“By making use of bona fide multi-omics profiles, these methods can outperform unmatched integration strategies and facilitate an experimental design for cross-modality in which multi-omics datasets are only collected in a subset of experiments.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [170] Ghazanfar, S. StabMap: Mosaic single cell data integration using non-overlapping features. Preprint at bioRxiv https://doi.org/10.1101/2022.02.24.481823 (2022). source
- Not checked yetcites [171] Gong, B. Cobolt: integrative analysis of multimodal single-cell sequencing data. Genome Biol. 22, 351 (2021). source
- Not checked yetcites [172] Ashuach, T. MultiVI: deep generative model for the integration of multi-modal data. Preprint at bioRxiv https://doi.org/10.1101/2021.08.20.457057 (2021). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“A recent unmatched method, graph-linked unified embedding (GLUE), achieves triple-omics integration while simultaneously inferring regulatory interactions.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [169] Cao, Z. J. & Gao, G. Multi-omics single-cell data integration and regulatory inference with graph-linked embedding. Nat. Biotechnol. 40, 1458–1466 (2022). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Other challenges include high sequencing costs and limited coverage of single cells, for which each omics layer can only be partially profiled, thus resulting in loss of important data.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Similarly, CellOracle179 leverages multi-omics data, either collected in parallel or integrated computationally, to learn gene regulatory networks and infer the results of in silico perturbations, whereas in silico ChIP–seq predicts transcription factor binding at individual cis-regulatory elements179.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [179] Kamimoto, K. Dissecting cell identity via network inference and in silico gene perturbation. Nature 614, 742–751 (2023). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Another method, DeepMAPS (deep learning-based multi-omics analysis platform for single-cell data), uses a five-step framework to preprocess data, generate an integrated cell–gene matrix specific to multi-omics data types, use a heterogeneous graph transformer model to generate a score for each cell indicating its gene-to-cell significance, generate clusters and ultimately elucidate diverse”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [175] Ma, A. et al. Single-cell biological network inference using a heterogeneous graph transformer. Nat. Commun. 14, 964 (2023). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Single-cell multi-omics have already become integral methods for elucidating the complexity of biological processes, especially when facing rare diseases and cell types.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite advancements in the many computational integration tools for multi-omics and multi-layered data, analysis of biological functionality of cell types and gene regulatory networks remains a computational challenge.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Most of the current spatial technologies are low throughput in the number of tissues they can process simultaneously and therefore cannot fully capture the 3D architecture of a tissue.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
In the paper
“whereas in silico ChIP–seq predicts transcription factor binding at individual cis-regulatory elements179.”
§ The technological landscape and applications of single-cell multi-omics > Computational tools used for integration of multi-omics data
What the sources say
- Not checked yetcites [179] Kamimoto, K. Dissecting cell identity via network inference and in silico gene perturbation. Nature 614, 742–751 (2023). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In the effort to capture more informative and complete genomic data, long-read technologies can advance the detection of genetic variation in cells, but still face limitations of low sequencing accuracy and difficulty in obtaining intact DNA and full-length RNA from clinical samples181.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
What the sources say
- Not checked yetcites [181] Sakamoto, Y., Sereewattanawoot, S. & Suzuki, A. A new era of long-read sequencing for cancer genomics. J. Hum. Genet. 65, 3–10 (2020). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, it is difficult to obtain matched or same-experiment datasets characterizing different omics layers along with gold-standard datasets, posing an urgent need for benchmarking multi-omics studies and generating guidelines for data analysis.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Finally, although many computational methods are offered for pseudotime analysis of scRNA-seq data, these methods are not always accurate in reconstructing the trajectory of cells through their developmental processes, which are complex and dynamic in nature.”
§ The technological landscape and applications of single-cell multi-omics > Conclusions and future perspective
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper relies on this without support.
Nuclear proteins are actively involved in gene regulation.
“Nuclear proteins are actively involved in gene regulation”
The paper relies on this without support.
TCRs and BCRs are crucial components of adaptive immunity.
“T cell receptors (TCRs) and B cell receptors (BCRs), which are crucial components of adaptive immunity”
The paper relies on this without support.
Organization of cellular compartments and intercellular interactions is fundamental to the function of multicellular organisms.
“The organization of cellular compartments and macro-structures and of intercellular interactions is fundamental to the function of multicellular organisms.”
The paper relies on this without support.
Clonal information can be encoded by DNA oligonucleotide barcodes to record all cell division events within an organism.
“Clonal information can be encoded by DNA oligonucleotide barcodes to record all cell division events within an organism”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“10× Genomic improved it and released 10× Visium, which possessed a higher spatial resolution [74].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [74]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tracing cell lineages
“Methods discussed above such as scTRIO-seq28 and scNMT-seq26”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
“single-cell triple omics sequencing (scTrio-seq) combined profiling of genome, methylome and transcriptome in 25 single cancer cells by applying scRRBS and whole-genome sequencing33”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ The technological landscape and applications of single-cell multi-omics > Research and clinical applications of single-cell multi-omics > Tracing cell lineages
“Methods discussed above such as scTRIO-seq28 and scNMT-seq26”
§ The technological landscape and applications of single-cell multi-omics > The landscape of single-cell multi-omics > Integrating transcriptome and epigenome
“single-cell nucleosome occupancy mapping, which is demonstrated in scNMT-seq29 and scNOMeRe-seq36”
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Self-citationComprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Self-citationThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Massively parallel digital transcriptional profiling of single cells
Zheng, G. X. Y., Terry, J. M., Belgrader, P., Ryvkin, P., Bent, Z. W., Wilson, R., Ziraldo, S. B., Wheeler, T. D., McDermott, G. P., Zhu, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14049 · Cited by 7,353
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets.
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., Bialas, A. R., Kamitaki, N., Martersteck, E. M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.002 · Cited by 7,110
Self-citationBuenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., & Greenleaf, W. J. (2013) · Nature Methods · doi:10.1038/nmeth.2688 · Cited by 6,422
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Dictionary learning for integrative, multimodal and scalable single-cell analysis
Hao, Y., Stuart, T., Kowalski, M. H., Choudhary, S., Hoffman, P., Hartman, A., Srivastava, A., Molla, G., Madad, S., Fernandez-Granda, C., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-01767-y · Cited by 5,631
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Research works printed but not linked: 2
- Oxford Nanopore Technologies. Oxford Nanopore Technologies announces new collaboration with 10x Genomics to make single-cell and spatial full-length isoform transcript sequencing accessible to any laboratory, https://nanoporetech.com/about-us/news/oxford-nanopore-technologies-announces-new-collaboration-10x-genomics-make-single (27 October 2022).
- Bio-Techne. Bio-Techne announces commercial release of RNAscope® HiPlex Assay: a multiplex in situ hybridization assay for tissues, https://investors.bio-techne.com/press-releases/detail/148/bio-techne-announces-commercial-release-of-rnascope (2016).
Cited by
Sorted by citations
Items 501–600 of 1,001
Advances and opportunities in methods to study protein translation - A review
Zhang, D., Gao, Y., Zhu, L., Wang, Y., & Li, P. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.129150 · Cited by 4
The Tumor Microenvironment and Immune Response in Breast Cancer
Monzavi‐Karbassi, B., Kelly, T. J., & Post, S. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020914 · Cited by 4
Harmonizing the Generation and Pre-publication Stewardship of FAIR Image DataPreprint
Bialy, N., Alber, F., Andrews, B., Angelo, M., Beliveau, B. J., Bintu, L., Boettiger, A. N., Boehm, U., Brown, C. M., Maina, M. B., et al. (2024) · PubMed · doi:10.48550/arxiv.2401.13022 · Cited by 4
Single-cell technologies meet Hi-C
Hughes, J. R., & Davies, J. O. J. (2024) · Nature Genetics · doi:10.1038/s41588-024-01855-y · Cited by 4
Towards a unified framework for single‐cell ‐omics‐based disease prediction through AI
Barberis, M., & Xie, J. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70290 · Cited by 4
Biologically Informed Variational Inference Enables Interpretable Cell Phenotyping and DiscoveryPreprint
Arnoldt, L., zu Belzen, J. U., Herrmann, L., Nguyen, K., Ishaque, N., Theis, F. J., Wild, B., & Eils, R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.10.657924 · Cited by 4
Harnessing high-throughput OMICS in emerging zoonotic virus preparedness and response activities
Loeb, K., Lemaille, C., Frederick, C., Wallace, H. L., & Kindrachuk, J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167337 · Cited by 3
Kim, H., Choi, S., Heo, H., Cho, S. H., Lee, Y., Kim, D., Jung, K. O., & Rhee, S. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc23183 · Cited by 3
Proteomic Analysis of Soybean Nodules: Insights into Efficient Nitrogen Fixation
Zhou, X., & Guo, T. (2025) · Molecular Soil Biology · doi:10.5376/msb.2024.15.0021 · Cited by 3
Wang, J., Huang, Y., & Winther, O. (2026) · Nature Computational Science · doi:10.1038/s43588-026-01016-7 · Cited by 3
Protoplast System for Seaweeds Research: Status and Future Implications
Gupta, V., & Ralph, P. J. (2025) · Springer eBooks · doi:10.1007/978-981-97-9427-0_13 · Cited by 3
Genetic influences on macrophage function and lipid uptake in atherosclerosis
O’Callaghan, C. A., & Jiang, J. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000986 · Cited by 3
Glial changes and gene expression in Alzheimer's disease from snRNA-Seq and spatial transcriptomics
Wei, S., Li, C., Li, W. Q., Yuan, F., Kong, J., Su, X., Huang, P., Guo, H., Xu, J., & Sun, H. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251330320 · Cited by 3
Yu, H., Wang, Y., Chen, Y., Zhang, R., Yu, S., Jin, X., & Zheng, Y. (2025) · Hygiene and Environmental Health Advances · doi:10.1016/j.heha.2025.100130 · Cited by 3
Qiao, Y., Zhou, L., Nie, J., Li, J., Hu, Y., Gao, P., Wu, B., Cheng, H., & Dai, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00274-7 · Cited by 3
Histone modifications: key mechanisms in embryo implantation of domestic animal
Sha, Y., Qin, X., & Pang, W. (2025) · Theriogenology · doi:10.1016/j.theriogenology.2025.117568 · Cited by 3
Refining cell subpopulation identification and cell fate mapping using cell energy
Long, C., Li, H., Li, Z., Zhang, J., Xi, Q., & Zuo, Y. (2025) · Expert Systems with Applications · doi:10.1016/j.eswa.2025.128999 · Cited by 3
Systems biology successes and areas for opportunity in prostate cancer
Orman, M. V., Graham, L. S., Cramer, S. D., & Costello, J. C. (2025) · Endocrine Related Cancer · doi:10.1530/erc-25-0067 · Cited by 3
Yang, H., Yang, J., Zheng, H., Dai, Y., Chen, X., Wu, J., Ma, X., & Cheng, H. (2025) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s533281 · Cited by 3
Interleukin Networks in GVHD: Mechanistic Crosstalk, Therapeutic Targeting, and Emerging Paradigms
Niu, Y., Liu, C., Li, P., Zhao, J., Jin, J., & Yang, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178620 · Cited by 3
ArchVelo: archetypal velocity modeling for single-cell multi-omic trajectories
Avdeeva, M., Walker, S. K., van der Veeken, J., Rudensky, A. Y., & Pritykin, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-74000-4 · Cited by 3
How FAIR is metadata for human pluripotent stem cells?
Hu, M., Ankeny, R. A., Santos, D., & Wells, C. A. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102644 · Cited by 3
Clinical advances and challenges of anti-angiogenic targeted therapy in gastric cancer
Wu, Z., Ni, J., & Xu, Q. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1654300 · Cited by 3
Epigenetic regulation of circulating tumor cells in precision oncology
Farah, H. S., Abosaoda, M. K., Mousa, H. M., Renuka Jyothi, S., Nayak, P. P., Janney, J. B., Singh, G., & Chauhan, A. S. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156282 · Cited by 3
Wang, Y., Ma, W., Ma, Y., Zhao, W., & Ma, X. (2025) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbbio.2025.3627901 · Cited by 3
A Single-Cell Omics Technical Guide for Advancing Neuropsychiatric Research
Casmey, K., Zimmermann, M., Xie, Y., Codeluppi-Arrowsmith, S. A., & Turecki, G. (2025) · Genes · doi:10.3390/genes16121394 · Cited by 3
RNA sequencing in ovarian cancer research: a comprehensive review
Shen, F., Li, C., Li, Y., Shen, Y., & Han, F. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01888-9 · Cited by 3
Targeting TIMM23 to overcome osteosarcoma chemoresistance
Tao, Z., Zou, P.-A., Yang, Z., Xiong, T., Deng, Z., & Chen, Q. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08106-w · Cited by 3
Li, H., Wang, J., Liu, Q., Zou, Q., & Luo, X. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf669 · Cited by 3
Bridging the Gap Between Static Histology and Dynamic Organ-on-a-Chip Models
Wang, Z., Naruse, K., & Takahashi, K. (2026) · Pathophysiology · doi:10.3390/pathophysiology33010010 · Cited by 3
Wang, J., Sun, Z., Zhou, Y., Wang, L., & Liu, J. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04885-3 · Cited by 3
Ding, Y., Jiang, Y., Wang, J., Tan, D., Su, Y., & Zheng, C. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag005 · Cited by 3
Single-Cell Transcriptomics and Computational Frameworks for Target Discovery in Cancer
Tarozzi, M. E., Derus, N. R., Polizzi, S., Sala, C., & Castellani, G. (2026) · Targets · doi:10.3390/targets4010006 · Cited by 3
Molehin, O. R., & Afolabi, A. T. (2026) · Clinical & Translational Oncology · doi:10.1007/s12094-026-04227-6 · Cited by 3
GATCL: graph attention network meets contrastive learning for spatial domain identification
Mu, J., Yao, Y., Chen, Q., Sun, J., & Zhao, T. (2026) · Briefings in Bioinformatics · doi:10.1093/bib/bbag043 · Cited by 3
Toward A Pre-disease State-centered New Paradigm in Multi-omics Research
Lu, C., Li, Y., & Du, Q. (2026) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzag016 · Cited by 3
Fan, Y., Su, Y., Hao, G., Wang, F., Chen, X., Wong, K., & Li, X. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519870123 · Cited by 3
The transformative role of single-cell analysis in multifactorial disorders research
Wang, C., Ko, C.-C., Kumar, S., Xuan, D. T. M., Lin, H.-R., Lee, Y.-K., Nguyen, N. U. N., Pei-Ming, Y., & Solomon, D. D. (2026) · Methods · doi:10.1016/j.ymeth.2026.03.009 · Cited by 3
Deciphering double-negative prostate cancer: from aggressive subtype to novel therapeutic paradigms
Wang, J., Wu, R., Tuo, Z., Okoli, U. A., Wang, Z., Chaipanichkul, P., Koh, S., Li, D., Lyu, Z., Cheema, U., et al. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-02795-2 · Cited by 3
Chronic Kidney disease and cognitive frailty in aging: molecular crosstalk and clinical implications
Cao, Y., Wang, Z., Xue, J., Wang, L., Qin, W., Sun, Q., & Chang, J. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1778574 · Cited by 3
Interpretable modality-aware mapping of gene regulation in single-cell multiomics with scMAGCA
Wang, Y., Zhou, Liu, W., Zhang, P., Cheng, Y., Su, Y., Wang, F., Wong, K., & Li, X. (2026) · Nature Communications · doi:10.1038/s41467-026-73055-7 · Cited by 3
Sahu, P., & Satapathy, T. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11050-6 · Cited by 3
A Age Related Vascular Senescence: Mystery of Blood-brain Barrier Dysfunction in Neurodegeneration
Behl, T., Jayabalan, K., Ballal, S., Sahoo, S., Chellammal, H. S. J., Gulati, M., Anand, K., Jha, S. K., & Gasmi, A. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05984-9 · Cited by 3
Mapping and engineering the human cell–cell interactome
Carlo, D. D., Morsut, L., McCain, M. L., Wright, H. J., Abedi, M. H., Yamada‐Hunter, S. A., Zhang, J. Z., Backus, K. M., Chung, E., Wang, Y., et al. (2026) · Nature Biotechnology · doi:10.1038/s41587-026-03177-2 · Cited by 3
Crosstalk between lactylation and other post-translational modifications in health and diseases
Qi, W., Su, J., He, X., Yang, F., Li, Q., & Li, B. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00500-w · Cited by 3
Chang, K., Serasanambati, M., Ogunlade, B., Hsu, H.-J., Agolia, J. P., Stiber, A., Gu, J., Chadokiya, J., Rodriguez, G. E., Singh, P., et al. (2026) · JCO Precision Oncology · doi:10.1200/po-25-00591 · Cited by 3
Uncovering intestinal macrophages through the integration of single-cell and spatial transcriptomics
Garrido-Trigo, A., Veny, M., & Salas, A. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00242-7 · Cited by 3
Li, Z., Li, X., Lin, J., Wang, Y., Cao, H., & Zhou, J. (2024) · Science China Life Sciences · doi:10.1007/s11427-023-2594-3 · Cited by 3
Star wars against leukemia: attacking the clones
Toma, M. M., & Skórski, T. (2024) · Leukemia · doi:10.1038/s41375-024-02369-6 · Cited by 3
Trends and Challenges of the Modern Pathology Laboratory for Biopharmaceutical Research Excellence
Sisó, S., Kavirayani, A. M., Couto, S. S., Stierstorfer, B., Mohanan, S., Morel, C., Marella, M., Bangari, D. S., Clark, E. S., Schwartz, A. J., et al. (2024) · Toxicologic Pathology · doi:10.1177/01926233241303898 · Cited by 3
Advancements in proteogenomics for preclinical targeted cancer therapy research
Suo, Y., Song, Y., Wang, Y., Liu, Q., Rodriguez, H., & Zhou, H. (2025) · Biophysics Reports · doi:10.52601/bpr.2024.240053 · Cited by 3
Zhu, W., Wu, X., Zhao, Z., Zhou, M. R., Zhang, T., Zhao, D., Jiang, N., Yang, X., Guo, H., Fang, N., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.4c05648 · Cited by 3
mitoXplorer 3.0, A Web Tool for Exploring Mitochondrial Dynamics in Single-cell RNA-seq Data
Haering, M., Bondio, A. D., Puccio, H. M., & Habermann, B. H. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169004 · Cited by 3
Challenges and Opportunities in Spatiotemporal Models of Mammalian Gastrulation
Rubinstein, H., Mayshar, Y., & Stelzer, Y. (2025) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101323-125216 · Cited by 3
Timoshevskiy, V. A., Timoshevskaya, N. Y., Eskut, K. I., Rajandran, K., & Smith, J. J. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2421883122 · Cited by 3
Yang, Y., Meng, L., Zhang, T., & Tan, J. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096372729250715050452 · Cited by 3
Emerging Trends and Future Perspectives in Bioanalysis
Gangadi, J. R., Swain, K., & Pattnaik, S. (2025) · Wiley eBooks · doi:10.1002/9781394314133.ch4 · Cited by 3
From cellular heterogeneity to precision medicine: single-cell multi-omics in CNS disease research
Liu, T., Zhang, Y., Hou, W., Hao, H., Geng, A., Zhao, G., & Zhang, Y. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1848558 · Cited by 3
Shin, S., Kim, Y.-J., Yun, H. G., Chung, H., Cho, H., & Choi, S. (2024) · ACS Nano · doi:10.1021/acsnano.3c10421 · Cited by 3
Verstappe, B., & Scott, C. L. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae077 · Cited by 3
George, S., & Johdi, N. A. (2025) · Current Molecular Medicine · doi:10.2174/0115665240355043250130110501 · Cited by 3
Dunkenberger, L., Li, D. Y., Karakikes, I., & Quertermous, T. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.05.001 · Cited by 3
From Cells to Selves and Back: Human Neurodiversity at Single-Cell Resolution
Lessi, M., Caporale, N., & Testa, G. (2025) · Physiology · doi:10.1152/physiol.00010.2025 · Cited by 3
Next-Generation Barcoding for Single-Cell Omics
Li, T., Gu, Z., & Zhou, G. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03587 · Cited by 3
A Mixed Reality and 2D Display Hybrid Approach for Visual Analysis of 3D Tissue MapsPreprint
Mörth, E., Nielsen, C. B., Turner, M., Xianhao, L., Keller, M. S., Beyer, J., Pfister, H., Chen, Z., & Gehlenborg, N. (2024) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/zka2j · Cited by 3
Yang, M., Iqfath, M., Meke, F. N., Qu, Z., Hernly, E., Su, P., Zhang, Z., & Laskin, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.04.611280 · Cited by 3
scPlantFormer: A Lightweight Foundation Model for Plant Single-Cell Omics AnalysisPreprint
Zhang, X., Xu, J., Chen, D., & Chen, L. (2024) · Research Square · doi:10.21203/rs.3.rs-5219487/v1 · Cited by 3
Novel Computational and Artificial Intelligence Models in Cancer Research
Liu, L., Li, F., Liu, X., Wang, K., & Zhao, Z. (2025) · Cancers · doi:10.3390/cancers17010116 · Cited by 3
Principled PCA separates signal from noise in omics count dataPreprint
Stanley, J. S., Yang, J., Li, R., Lindenbaum, O., Kobak, D., Landa, B., & Kluger, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.03.636129 · Cited by 3
Ohno, H., Nishimura, T., Kainoh, K., Ohashi, Y., Onodera, N., Kano, M., Sari, L. N., Masuda, M., Tamura, Y., Nishino, T., et al. (2026) · The FEBS Journal · doi:10.1111/febs.70286 · Cited by 2
Rogal, J., Zamproni, L. N., Nikolakopoulou, P., Ygberg, S. E., Wedell, A., Wredenberg, A., & Herland, A. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae021 · Cited by 2
Attention-Fusion Model for Multi-omics (AMMO) Data Integration in Lung Adenocarcinoma
Li, W., Muneer, A., Waqas, M., Zhou, X., & Wu, J. (2024) · Lecture notes in computer science · doi:10.1007/978-3-031-73360-4_6 · Cited by 2
Single-cell mosaic integration and cell state transfer with auto-scaling self-attention mechanism
Rong, Z., Song, J., Yu, Y., Mi, L., Qiu, M., Song, Y., & Hou, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae540 · Cited by 2
GEEES: inferring cell-specific gene–enhancer interactions from multi-modal single-cell data
Chen, S., & Keleş, S. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae638 · Cited by 2
Single same-cell multiome for dissecting key plant traits
Garg, R., Sahu, S. K., & Jain, M. (2024) · Trends in Plant Science · doi:10.1016/j.tplants.2024.10.008 · Cited by 2
Unlocking cross-modal interplay of single-cell joint profiling with CellMATE
Wang, Q., Zhang, B., Guo, Y., Gong, L., Li, E., & Yang, J. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae582 · Cited by 2
Designing the Proteome with Chemical Tools: Degrons and Beyond
Seabrook, L. J., Livelo, C. R., & Albrecht, L. V. (2025) · ChemBioChem · doi:10.1002/cbic.202500345 · Cited by 2
Characterization of human CMV-specific CD8+ T cells using multi-layer single-cell omics
Gemünd, I. D., Bonaguro, L., Becker, M., Müller, S. M., Joos, C., Domenico, E. D., Aschenbrenner, A. C., Schultze, J. L., Moosmann, A., & Beyer, M. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101085 · Cited by 2
Ma, K., Xu, J., Wang, C., Cao, X., Yu, W., Xi, J., Zhang, X., Zhan, J., Liu, Y., Yü, A., et al. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1590216 · Cited by 2
Secondary Metabolism in Tea Plants: Pathways and Regulatory Mechanisms
Huang, B., & Zhang, J. (2024) · Journal of Tea Science Research · doi:10.5376/jtsr.2024.14.0029 · Cited by 2
Beyond genomics: a multiomics future for parasitology
Doherty, J., Magaña, A. A., Arad, M., Chen, J., Chi, L. S., Fordwour, O. B., Palumbo, A., Rogalski, J. C., Shi, Y., Song, L., et al. (2025) · Trends in Parasitology · doi:10.1016/j.pt.2025.07.006 · Cited by 2
Zhou, J., Xue, J., Li, Y., Liu, F., Du, F., & Yu, Z. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf400 · Cited by 2
Plaza‐Florido, A., Perlsteyn, M., Haddad, F., Cooper, D. M., Bar‐Yoseph, R., Lucía, A., & Radom‐Aizik, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625437 · Cited by 2
Plasma Proteomic Signatures for Diverticulitis Risk Stratification
Ueland, T. E., Shelley, J. P., Mosley, J. D., Robinson, J. R., Gamazon, E. R., Maguire, L. H., Peek, R. M., & Hawkins, A. T. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.06.093 · Cited by 2
Zhu, X., Gao, Q., Dai, X., Sun, B., Li, Y., Zhai, H., & Shan, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652645 · Cited by 2
SuperGLUE facilitates an explainable training framework for multi-modal data analysis
Liu, T., Zhao, J., & Zhao, H. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101167 · Cited by 2
Wu, X., Cai, L., Liu, Y., Wang, B., Xia, T., & Liu, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0332988 · Cited by 2
Zhao, J., He, J., Guan, P., Bao, H., Zhao, X., Zhao, C., Qin, W., Lu, X., & Xu, G. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c03611 · Cited by 2
Zhang, T., Yang, Y., Meng, L., & Tan, J. (2025) · Current Science Engineering and Technology · doi:10.2174/0130506115393405250919155253 · Cited by 2
Ji, L., Li, X., & Gao, B. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108753 · Cited by 2
Xin, Y., Jin, Y., Qian, C., Blackshaw, S., & Qian, J. X. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.101217 · Cited by 2
Multiomics Approaches with Advanced Breeding Tools for Crop Improvement
Aggarwal, G., Kumari, S., Kumari, N., Mehra, K., Tiwari, M., Singh, M. K., & Kumar, B. (2025) · CABI eBooks · doi:10.1079/9781800628717.0006 · Cited by 2
Hu, Z., Zhou, Y., Xie, L., Zhang, W., & Rao, H. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01925-3 · Cited by 2
Zeng, T., Li, B., Xu, J., Sun, Y., Xiao, Y., Zhou, Z., Hua, Y., Wu, S., Shi, H., Li, G., et al. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06259 · Cited by 2
Deciphering the rules of regulated cell death subroutines by in silico methods
Zhang, L., Dai, Y., Li, Q., Jiang, X., & He, G. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.12.016 · Cited by 2
Deep Self-Reinforced Multi-View Subspace Clustering for Cancer Subtyping
Liu, C., Zheng, B., Wang, J., Wang, X., Gao, H., Wang, F., Shen, W., & Wu, S. (2025) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2025.3646614 · Cited by 2
MVPHI: a multi-view learning framework for predicting complex microbial interactions
Xie, Y., Pan, J., Li, D., Wang, Q., Sun, Y., & Wang, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-32359-2 · Cited by 2
Judge, E., Gramatikoff, K., Milović, L., Minchev, A., & Karabaliev, M. (2026) · The EuroBiotech Journal · doi:10.2478/ebtj-2026-0001 · Cited by 2
Cytopathologic Diagnosis of Lymphomas in Serous Effusions, Cerebrospinal and Vitreous Fluid
Michelow, P. M., Coetzee, L., & Razack, R. (2026) · Acta Cytologica · doi:10.1159/000550549 · Cited by 2
Single-nucleus multiple-organ chromatin accessibility landscape in the adult rat
Li, R., Yuan, Y., Duan, S., Deng, Q., Ma, W., Liu, C., Gao, P., Yuan, Y., & Liu, C. (2026) · GigaScience · doi:10.1093/gigascience/giag013 · Cited by 2
Metadata
- Authors
- Baysoy, A., Bai, Z., Satija, R., & Fan, R.
- Affiliations
- Yale University (US)
- New York Genome Center (US)
- Yale Cancer Center (US)
- Corresponding author
- Fan, Rong
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2023-06-06
- Volume
- 24
- Issue
- 10
- Pages
- 695-713
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- PMC
- PMC10242609
- OpenAlex
- W4379521442
- Semantic Scholar
- da7c7d871d905c60ababe567260d597cc07919f0
- Cited by
- 1,037
- References
- 210
- Citations by year
- 2026: 290 · 2025: 415 · 2024: 301 · 2023: 29
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion, other-oa)
- PubMed Central (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Funders
- Yale University
- National Institutes of Health (1rf1mh128876-01)
- National Institute on Aging (U54AG076043, U54AG079759)
- National Institute of Mental Health (RF1 MH128876)
- National Cancer Institute (UH3CA257393, UG3CA257393, R01CA245313, U54CA274509)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- single-cell multi-omics, single-cell transcriptomics, single-cell proteomics, single-cell metabolomics, single-cell epigenomics, lineage tracing, cell atlases, tumor immunology, cancer genetics, spatial omics, multi-omics integration, bioinformatics software
- MeSH terms
- Epigenome, Multiomics, Cell Lineage, Computational Biology, Metabolome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review